GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Elevai Labs Inc.
The stock price of Elevai Labs, a company producing exosome-based cosmetics, reflects its ability to carve out a niche in a highly competitive market. Its price trajectory will depend on brand strength, distribution, and consumer trends in the beauty industry.
Share prices of companies in the market segment - Pharma skin
Elevai Labs is an aesthetic medicine company that develops and markets exosome-based skincare products. We've categorized it as "Pharma: Skin." The chart below shows how the market views innovative biotechnologies in cosmetology.
Broad Market Index - GURU.Markets
Elevai Labs is a company that develops and markets skincare products based on stem cell-derived exosomes. It is a component of the GURU.Markets index. The chart below represents the market. See how this stock compares to the biotech sector.
Change in the price of a company, segment, and market as a whole per day
ELAB - Daily change in the company's share price Elevai Labs Inc.
Elevai Labs Inc.'s daily price change reflects volatility in the aesthetics sector. The metric demonstrates sensitivity to consumer trends and demand for its skincare products.
Daily change in the price of a set of shares in a market segment - Pharma skin
Elevai Labs develops skincare products based on exosomes, a cutting-edge biotechnology. The aesthetic medicine and cosmeceuticals market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how the market is responding to ELEVAI Labs' innovations.
Daily change in the price of a broad market stock, index - GURU.Markets
Elevai Labs is a pharmaceutical company focused on dermatology. Its shares are responding to the success of its drug commercialization and clinical trial results. The dynamics of this niche healthcare segment are part of a larger and more diverse picture of the overall stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Elevai Labs Inc.
Elevai Labs Inc.'s year-over-year performance tells the story of its work in the aesthetic medicine market. Its market cap growth over the past 12 months reflects demand for its exosome-based serums, which are used to accelerate skin recovery after procedures. Its valuation is a bet that its scientific approach will find a niche in skincare.
Annual dynamics of market capitalization of the market segment - Pharma skin
Elevai, as a company operating in the field of aesthetic medicine, is betting on trends in cosmetology. Its performance relative to the sector will determine how well its products are accepted in the market and how it is impacted by consumer spending on beauty.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Elevai Labs, with its exosome-based cosmeceuticals, is a hybrid of science and beauty. Its market dynamics are a bet on consumers' willingness to pay for high-tech cosmetics. Success depends on both proven effectiveness and clever marketing in the luxury segment.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Elevai Labs Inc.
Elevai Labs is a cosmetics company using exosomes in skincare products. Its monthly growth reflects rising sales through dermatologists and beauty salons, as well as consumer trends in premium cosmetics.
Monthly dynamics of market capitalization of the market segment - Pharma skin
The cosmeceuticals and aesthetic medicine market is a segment where science meets the beauty industry. Its market capitalization dynamics, shown in the graph, reflect the demand for innovative skincare products. Companies like Elevai Labs offer solutions in this area.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Elevai Labs, a company in the aesthetic medicine sector, relies on consumer spending on beauty. The company's stock is cyclical, as people spend more on procedures during good times, but innovation can allow the company to grow regardless of the market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Elevai Labs Inc.
Shares of Elevai Labs, a company developing exosome-based cosmetics, reflect trends in the beauty industry. Weekly price movements are sensitive to news of new product launches and consumer preferences in skincare. The chart below shows how short-term changes in the cosmeceutical world are impacting the company.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Elevai Labs operates in the skincare market using biotech developments. This places it on the border between the consumer and biotech sectors. Compare its weekly performance to the industry to understand whether the market views it as a high-potential science-based company or just another cosmetics brand.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Elevai Labs combines biotechnology and cosmetology. This chart compares its weekly performance with the market to assess whether it is more influenced by general consumer trends or scientific developments, which are typical of the volatile biotech sector.
Market capitalization of the company, segment and market as a whole
ELAB - Market capitalization of the company Elevai Labs Inc.
The valuation of Elevai Labs Inc. in the chart is a bet on its innovative cosmetics using exosomes for skin rejuvenation. The company's market cap reflects investors' faith in the scientific basis of its products and their potential in the premium cosmetics market. The chart illustrates the risks and hopes associated with this biotech approach to skincare.
ELAB - Share of the company's market capitalization Elevai Labs Inc. within the market segment - Pharma skin
Elevai Labs's position in the skincare sector is a reflection of its scientific approach. The company uses stem cell-derived exosomes to create next-generation cosmetics. Its market share reflects the potential of this cutting-edge technology in the highly competitive beauty industry.
Market capitalization of the market segment - Pharma skin
This graph shows the overall market capitalization of the aesthetic medicine and cosmeceuticals industry. Elevai Labs is a niche player specializing in exosome-based products. The dynamics in the chart reflect the growing demand for science-based skincare solutions.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart visualizes the market value of the science behind skincare. Elevai Labs' market cap reflects its belief in its exosome-based cosmetic products. The line shows how cutting-edge biotechnologies are attempting to capture a share of the multi-billion-dollar global beauty industry.
Book value capitalization of the company, segment and market as a whole
ELAB - Book value capitalization of the company Elevai Labs Inc.
Elevai Labs Inc.'s book value is its scientific and production capital. The chart below reflects the valuation of its exosome skincare technology patents and its manufacturing capacity. The dynamics illustrate the company's investment in the development and production of innovative cosmetic products.
ELAB - Share of the company's book capitalization Elevai Labs Inc. within the market segment - Pharma skin
Elevai Labs's core assets are its laboratories and production facilities for creating innovative exosome-based cosmeceutical products. The chart shows the company's share of this high-tech infrastructure, which sits at the intersection of biotechnology and the beauty industry.
Market segment balance sheet capitalization - Pharma skin
Against the backdrop of the capital-intensive pharmaceutical industry, Elevai Labs has chosen the niche path of cosmeceuticals. Its value lies in exosome technology. The graph illustrates the material strength of the industry, while Elevai builds its success on science, not on scale.
Book value of all companies included in the broad market index - GURU.Markets
Elevai Labs develops skincare products based on exosomes derived from stem cells. The company's assets include cutting-edge laboratories and unique biotechnological processes. The graph below shows the material weight behind these "cosmetics of the future," born in a test tube.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Elevai Labs Inc.
Elevai Labs is a company operating in the field of aesthetic medicine. Its market capitalization is based on its patented exosome technology, which is used in skincare products. Investors value its science and its brand in the beauty industry.
Market to book capitalization ratio in a market segment - Pharma skin
Elevai Labs Inc. is a biotech company developing exosome-based skincare products. Its value lies in its unique technology and brand. This chart shows the market premium paid for its innovations in aesthetic medicine over and above the value of its tangible assets.
Market to book capitalization ratio for the market as a whole
Elevai Labs is a biopharmaceutical company specializing in the development of aesthetic dermatology and skin care products. This chart reflects how the market values their scientific developments and patents in the field of regenerative medicine. This assessment demonstrates investors' confidence in the commercial potential of their cosmetic products.
Debts of the company, segment and market as a whole
ELAB - Company debts Elevai Labs Inc.
Elevai Labs, a company in the aesthetics field, is leveraging its financial structure to develop and commercialize its exosome-based skincare products. This chart shows how the company is investing in research and marketing to carve out a niche in the fast-growing but highly competitive cosmeceuticals market.
Market segment debts - Pharma skin
Elevai Labs develops and markets exosome-based skincare products. This rapidly growing segment of the beauty industry requires significant investment in R&D and marketing. This chart shows how the company's leverage reflects its strategy to advance its innovative technology and capture market share in the competitive cosmeceuticals market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Elevai Labs Inc.
BloomZ Inc. develops a communications platform for schools, teachers, and parents. In the education technology (EdTech) sector, scaling quickly is essential. This chart shows how the company uses capital to attract new schools to its platform and for technological development to stay ahead of the competition.
Market segment debt to market segment book capitalization - Pharma skin
Elevai Labs is a company that develops and markets skincare products based on exosomes derived from stem cells. This chart compares its debt load to the overall market capitalization of the pharmaceutical sector. It illustrates how this company, operating at the intersection of biotechnology and cosmetology, finances its innovative developments.
Debt to book value of all companies in the market
Elevai Labs Inc. develops and markets exosome-based skincare products. The beauty industry is highly competitive and requires significant marketing and branding expenditures. This graph of overall debt trends helps assess how the young company finances its research and development and competes for consumer attention in the crowded cosmetics market.
P/E of the company, segment and market as a whole
P/E - Elevai Labs Inc.
This chart for Elevai Labs, a company producing exosome-based cosmetics, shows a valuation at the intersection of biotech and beauty. The price-to-earnings ratio will reflect demand for its innovative products. This is a bet that this scientific approach to skincare will find a premium buyer.
P/E of the market segment - Pharma skin
Elevai Labs is a company operating in the field of aesthetic medicine. It develops and markets skincare products based on stem cell-derived exosome technology. This chart shows the average valuation for the pharmaceutical sector, reflecting how investors evaluate innovations at the intersection of biotechnology and the beauty industry.
P/E of the market as a whole
Elevai Labs develops and markets skincare products based on exosomes—microscopic vesicles derived from stem cells. The company operates at the intersection of biotechnology and the beauty industry. This chart, reflecting overall consumer sentiment, helps understand how the market evaluates innovative products in the premium cosmetics sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Elevai Labs Inc.
Elevai Labs is a company specializing in the development and sale of exosome-based skincare products. This chart illustrates future revenue expectations, which depend on consumer demand for innovative cosmeceuticals and the company's ability to market its products in a highly competitive market.
%20P%2FE%20Elevai%20Labs%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Elevai-Labs-Inc.&v=1772636730912 "Chart of the company's future (projected) P/E Elevai Labs Inc.")
Future (projected) P/E of the market segment - Pharma skin
Elevai Labs develops exosome-based skincare products. This chart compares the company's future profitability expectations with those of the biotech and cosmetics sectors. It demonstrates the extent to which investors believe in the scientific validity of its products and its ability to capture market share in the crowded premium cosmetics market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772636730924 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Elevai Labs develops and markets skincare products based on stem cell-derived exosomes. Demand for premium cosmetics is highly dependent on consumer discretionary spending. This graph, reflecting overall economic confidence, is an indicator of people's willingness to spend money on innovative and expensive beauty and health products.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772636730934 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Elevai Labs Inc.
Elevai Labs develops and markets exosome-based skincare products. The company's financial success depends on consumer and professional acceptance of its technology, as well as on the effectiveness of its marketing and distribution. This chart shows the financial results of a startup in the highly competitive beauty industry striving to carve out a niche.
Profit of companies in the market segment - Pharma skin
Elevai Labs develops and markets skincare products based on stem cell-derived exosomes. This graph, showing overall profitability in the sector, reflects the demand for innovative cosmetic solutions. Elevai's success in promoting its high-tech products directly impacts the development and profitability of the entire aesthetic medicine industry.
Overall market profit
Elevai Labs operates at the intersection of biotechnology and cosmetology, developing exosome-based skincare products. The company aims to fill the niche of science-based cosmetics. Its success depends on clinically proven product efficacy and a strong marketing strategy, rather than on general economic trends.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Elevai Labs Inc.
Elevai Labs develops and markets exosome-based skincare products. The company's future profit projections are based on consumer demand for innovative premium cosmetics. Analysts estimate growth in sales through clinics and online channels, as well as the brand's strength in the competitive beauty industry.
%20profit%20of%20the%20company%20Elevai%20Labs%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Elevai-Labs-Inc.&v=1772636731051 "Graph of future (projected) profit of the company Elevai Labs Inc.")
Future (predicted) profit of companies in the market segment - Pharma skin
Elevai Labs develops and commercializes skincare products based on stem cell-derived exosomes. This chart shows revenue projections for the dermatological pharmaceutical and cosmetics sectors. It helps assess how the company's innovative approach to skin rejuvenation compares to overall beauty industry trends.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772636731085 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
Elevai Labs develops exosome-based cosmetics. The premium cosmetics market is highly dependent on discretionary spending. This chart, illustrating economic forecasts, is an important indicator for Elevai. During periods of rising income and confidence, consumers, especially women, are more willing to spend on innovative and expensive skincare products.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772636731094 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Elevai Labs Inc.
Elevai Labs develops and markets exosome-based skincare products. For a company in the fast-growing biotech cosmeceuticals niche, this metric is crucial. It demonstrates the premium investors are willing to pay for each dollar of revenue, believing in the scientific validity and premium positioning of its products.
P/S market segment - Pharma skin
Elevai Labs develops and commercializes skincare products based on stem cell-derived exosomes. The company's technology is aimed at skin rejuvenation and restoration. This chart reflects the market premium the biotech cosmeceuticals sector is willing to pay for revenue, demonstrating confidence in the innovation and market potential of Elevai's products.
P/S of the market as a whole
Elevai Labs develops and commercializes skincare products based on stem cell-derived exosomes. This chart shows how the market values innovative companies in the highly competitive beauty industry, where branding and science play a key role, compared to the average.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Elevai Labs Inc.
Elevai Labs is a biotech company developing exosome-based aesthetic skincare products. This chart shows how investors value the company relative to its future revenue. It reflects the market's confidence in the scientific validity of its products and the growing demand for innovative solutions in cosmetology.
%20P%2FS%20Elevai%20Labs%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Elevai-Labs-Inc.&v=1772636731157 "The graph of the company's future (projected) P/S Elevai Labs Inc.")
Future (projected) P/S of the market segment - Pharma skin
Elevai Labs develops and markets skincare products based on stem cell-derived exosomes. The chart shows the average estimated future revenue in the dermatological pharmaceutical sector. It helps understand how investors view Elevai's innovative technology and its potential in the highly competitive premium cosmeceuticals market.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772636731161 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
Elevai Labs (ELAB) develops and markets exosome-based skincare products. Their success depends on innovations in cosmeceuticals and consumer spending on premium beauty products. This chart is important because economic optimism directly impacts people's willingness to spend money on luxury beauty products.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772636731168 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Elevai Labs Inc.
This chart shows the revenue of Elevai Labs, a company operating at the intersection of biotechnology and cosmetology. Revenue is generated from sales of innovative skincare products based on exosomes. This growth reflects demand for science-based cosmetics and the brand's successful promotion among professionals and consumers.
Sales of companies in the market segment - Pharma skin
Elevai Labs Inc. develops and markets exosome-based skincare products. Its sales structure shows how much revenue comes from the professional channel (cosmetologists, clinics) and how much comes from direct-to-consumer sales. This reflects its focus on a science-based approach to aesthetic medicine.
Overall market sales
Elevai Labs Inc. develops and markets exosome-based skincare products. The premium cosmetics market is directly dependent on consumer discretionary spending. This graph, illustrating overall purchasing power, is a barometer for the beauty industry. Its growth signals people's willingness to invest in high-end and innovative personal care products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Elevai Labs Inc.
Elevai Labs develops and markets exosome-based skincare products. The company's future sales depend on consumer and professional acceptance of its technology, as well as marketing effectiveness. This chart reflects analysts' expectations for premium cosmeceutical market growth and brand popularity.
%20sales%20of%20the%20company%20Elevai%20Labs%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Elevai-Labs-Inc.&v=1772636731197 "Schedule of future (projected) sales of the company Elevai Labs Inc.")
Future (projected) sales of companies in the market segment - Pharma skin
Elevai Labs Inc. develops and markets skincare products based on exosomes, a cutting-edge biotechnology. This chart shows the forecast for the dermatological pharmaceutical sector. It reflects the growing demand for science-based and highly effective products in the beauty industry, a key market for Elevai's innovations.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772636731202 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
The dynamics of consumer spending on cosmetics and personal care, shown in this chart, are an indicator for Elevai Labs. The company develops exosome-based cosmetics. Demand for premium and innovative cosmetics is growing along with consumer income and confidence.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772636731204 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Elevai Labs Inc.
Elevai Labs develops and markets skincare products based on exosome technology. This chart shows the company's financial performance at the market launch stage of an innovative product. Profitability depends on building a strong brand, recognition from specialists and consumers, and scaling up production.
Market segment marginality - Pharma skin
Elevai Labs develops and markets skincare products based on exosomes—cutting-edge regenerative components. The company's profitability depends on the popularity of its innovative cosmetics. This chart shows the average profitability in related sectors. It helps assess how successfully Elevai Labs is monetizing scientific advances in the beauty industry.
Market marginality as a whole
Elevai Labs develops and markets exosome-based skincare products. Demand for premium cosmetics is highly dependent on consumer discretionary spending. This chart serves as an indicator of consumer confidence, showing whether people have the spare cash for expensive, innovative personal care products or are switching to more affordable options.
Employees in the company, segment and market as a whole
Number of employees in the company Elevai Labs Inc.
Elevai Labs Inc. develops and markets exosome-based skincare products. This chart reflects the size of their team of scientists, marketing, and sales specialists. The growth in the chart reflects their efforts to commercialize their innovative technology and expand their presence in the highly competitive aesthetic medicine and cosmetology market.
Share of the company's employees Elevai Labs Inc. within the market segment - Pharma skin
Elevai Labs specializes in developing skincare products based on exosomes—cutting-edge regenerative components. This chart shows the company's share of the total number of specialists in the biotech cosmeceuticals niche. This reflects its science-intensive approach and innovative positioning in the skincare market.
Number of employees in the market segment - Pharma skin
Elevai Labs Inc. develops and markets skincare products based on stem cell-derived exosomes. This chart, illustrating employment in the pharmaceutical and cosmeceutical skincare sector, is indicative. The growing number of scientists and dermatologists in this niche indicates a high demand for innovative and scientifically proven skin rejuvenation solutions.
Number of employees in the market as a whole
Elevai Labs develops exosome-based cosmetics. This premium segment of the beauty market is directly dependent on consumer confidence. This overall employment graph is an indicator of purchasing power. The growing number of people with high disposable income is driving demand for innovative and high-end skincare products like those offered by Elevai.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Elevai Labs Inc. (ELAB)
Elevai Labs specializes in aesthetic dermatology using exosomes. It represents the intersection of biotech and cosmetics. This chart reflects the company's high intellectual capital valuation. The company's value lies in its scientific platform (exosome technology) and patents, not its manufacturing personnel. The market values the science behind its skincare products.
%20of%20the%20company%20Elevai%20Labs%20Inc.%20(ELAB)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Elevai-Labs-Inc.-ELAB&v=1772636731336 "Chart of market capitalization per employee (in thousands of dollars) of the company Elevai Labs Inc. (ELAB)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Elevai Labs works in the field of regenerative cosmetology using exosomes. It's a high-tech business where value is created through scientific research and patents, not mass production. The chart shows how the market values the company's intellectual capital per employee, an important indicator for knowledge-intensive industries.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772636731340 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Elevai Labs develops and markets exosome-based skincare products, a high-tech niche in the beauty industry. The high employee value, visible in this graph, reflects the value of scientific research and intellectual property, where a small team creates innovative products with high margins.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772636731344 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Elevai Labs Inc. (ELAB)
Elevai Labs works in the field of medical aesthetics, developing "stem cells" for skincare. This is the intersection of biotech and cosmeceuticals. This graph shows how successfully their small team (scientists and marketers) commercializes this premium technology, balancing R&D costs with revenue from sales of their high-margin products.
%20Chart%20Elevai%20Labs%20Inc.%20(ELAB)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Elevai-Labs-Inc.-ELAB&v=1772636731346 "Company Profit Per Employee (in thousands of dollars) Chart Elevai Labs Inc. (ELAB)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Elevai Labs specializes in the development and distribution of skincare products. This metric demonstrates how effectively the company manages its brand and distribution channels. In the beauty industry, high profit per employee is often the result of strong marketing, premium pricing, and efficient distribution through online platforms.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772636731349 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Elevai Labs (ELAB) is an aesthetic medicine company producing skincare serums based on exosomes (stem cells). This is a biotech company at the intersection of cosmeceuticals. Profit is generated by the high added value of this science-intensive product. This indicator demonstrates how, in the MedTech/cosmeceutical sector, high product margins enable high profits with a small workforce.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772636731351 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Elevai Labs Inc. (ELAB)
Elevai Labs develops exosome-based skincare products. This chart shows how the company is commercializing its research. Increased revenue per employee will indicate the popularity of their innovative cosmetics and the effectiveness of their sales strategy.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Elevai-Labs-Inc.-ELAB&v=1772636731356 "Sales chart per company employee Elevai Labs Inc. (ELAB)")
Sales per employee in the market segment - Pharma skin
Elevai Labs operates at the intersection of biotech and cosmeceuticals. They use exosome (stem cell) technology to create premium skincare products. This chart demonstrates the productivity of their R&D and marketing teams. It reflects their ability to sell high-tech (and expensive) cosmetics through dermatologists and salons.
Sales per employee for the market as a whole
Hope Bancorp (HOPE) is a bank focused primarily on the Korean-American community. Like any bank, its business is managing interest margins (the difference between deposits and loans) and providing services. This chart, in banking, reflects operational efficiency. It shows how much income (interest and fees) each employee generates, which is directly related to the digitalization of services.
Short shares by company, segment and market as a whole
Shares shorted by company Elevai Labs Inc. (ELAB)
Elevai Labs (ELAB) operates in the hyped-up aesthetic medicine (cosmetology) sector, offering exosome-based products. This chart tracks bearish bets. The shorts could reflect skepticism about the scientific validity of this technology or the intense competition in the anti-aging market.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Elevai-Labs-Inc.-ELAB&v=1772636731373 "Short Shares Chart for the Company Elevai Labs Inc. (ELAB)")
Shares shorted by market segment - Pharma skin
Elevai Labs (ELAB) operates in the aesthetic medicine niche, offering exosome-based skincare serums. The chart below shows the overall short position in the biotech sector. It illustrates how skeptical investors are about the commercial potential of new cosmetic technologies.
Shares shorted by the overall market
Elevai Labs operates in the "medical" cosmeceuticals sector, selling exosome-based serums. This chart reflects the general fear of a recession. When investors are afraid, they expect consumers to cut back on expensive, "science-intensive" skincare products, preferring cheaper alternatives. This threatens ELEVAI Labs' growth plans.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Elevai Labs Inc. (ELAB)
For Elevai Labs, this oscillator is a barometer of hype in "stem" skin technologies. The company sells cosmetics (exosomes) that supposedly rejuvenate skin. "Overheating" (above 70) occurs with announcements of partnerships with clinics. Skepticism about effectiveness, competition in luxury cosmetics, and regulatory risks lead to "oversold" conditions.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Elevai-Labs-Inc.-ELAB&v=1772636731398 "RSI 14 indicator chart for the company's stock Elevai Labs Inc. (ELAB)")
RSI 14 Market Segment - Pharma skin
Elevai Labs is a biotech company working in the field of medical aesthetics. They have developed exosomes (EGF)—post-procedure skin care products that promote regeneration. This chart reflects the overall sentiment in the biotech sector and helps assess how the market views this speculative industry.
RSI 14 for the overall market
Elevai Labs (ELAB) operates in the aesthetic medicine industry, developing skincare products. This sector relies on discretionary consumer spending. This market "temperature" chart helps gauge this confidence. During periods of market euphoria (overbought), people are more willing to spend on beauty. During periods of panic (oversold), these spending patterns are among the first to be curtailed.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ELAB (Elevai Labs Inc.)
Elevai Labs is a medical aesthetics company developing skincare serums (exosomes) designed for post-procedure recovery (such as microneedling). This chart shows the analysts' speculative 12-month average price target, based on their belief in in-clinic sales growth.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ELAB-Elevai-Labs-Inc.&v=1772636731447 "A chart showing analyst consensus forecasts for the expected stock price. ELAB (Elevai Labs Inc.)")
The difference between the consensus estimate and the actual stock price ELAB (Elevai Labs Inc.)
Elevai Labs is a biotech company specializing in "exosomes"—microscopic vesicles that cells use to communicate. Their goal is to use them in aesthetic medicine (skin care). This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and the forecast, reflecting their faith in this "high-tech" cosmetics company.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ELAB-Elevai-Labs-Inc.&v=1772636731449 "A chart showing the difference between the consensus forecast and the actual stock price. ELAB (Elevai Labs Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Elevai is an R&D biotech company developing cosmeceuticals based on exosomes (signaling vesicles) from stem cells for skin rejuvenation. This chart reflects the general expectations of analysts across the skin pharma sector. It shows whether experts believe in stem cell technologies in cosmetology.
Analysts' consensus forecast for the overall market share price
Elevai Labs is a cosmeceutical company. They develop skincare products (serums) using stem cell-derived technologies. This chart shows the overall risk appetite in the market. For ELEVAI Labs, which operates at the intersection of biotech and wellness, overall market optimism (the rising chart) is critical for funding and marketing.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Elevai Labs Inc.
Elevai Labs makes stem cell cosmetics. Their key feature isn't the stem cells themselves, but rather exosomes (signaling vesicles), which they harvest from stem cells and sell (as a serum) to dermatologists for skin rejuvenation. This chart is a summary of their B2B aesthetics business. It reflects their (unprofitable) sales growth and their reliance on the exosome hype.
AKIMA Market Segment Index - Pharma skin
Elevai Labs is a medical aesthetics company at the forefront of science. They use exosomes (derived from stem cells) to create skin and hair care products. This chart compares their composite index to the sector, showing how their high-tech cosmetics outperform the competition.
The AKIM Index for the overall market
Elevai Labs is an aesthetic biotech company developing skincare products based on exosomes (stem cells). This chart, reflecting the market average, is just a backdrop. It helps assess how this niche market in the beauty and wellness industry stacks up against overall macroeconomic trends.
